Glenmede Trust’s Vertiv VRT Stock Holding History

Glenmede Trust’s Portfolio VRT Stock Details VRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.77M	Buy	8,261 +4,708	+133%	+$1.49M	0.01%	533
2026 Q1	$890K	Buy	+3,553	New	+$789K	﹤0.01%	777
2024 Q3	–	Sell	-2,401	Closed	-$208K	–	1432
2024 Q2	$208K	Buy	+2,401	New	+$219K	﹤0.01%	1186

Other funds holding VRT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Glenmede Trust's VRT Position: Q2 2026 in Review

Glenmede Trust increased its Vertiv (VRT) stake by 133% in Q2 2026, buying an estimated $1.49M and bringing the position to 8,261 shares worth $2.77M. The position accounts for 0.01% of the portfolio, ranked #533.

Glenmede Trust first reported a position in VRT in Q2 2024 and has held it in 3 quarters since. 2,053 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

Glenmede Trust held 8,261 shares of Vertiv worth $2.77M as of Q2 2026.
Glenmede Trust bought 4,708 Vertiv shares in Q2 2026, an estimated $1.49M.
Vertiv made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #533 holding.
Glenmede Trust first reported a position in Vertiv in Q2 2024 and has held it in 3 quarters since.
2,053 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.